Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.42 USD | -2.30% | +18.31% | -43.67% |
Jul. 02 | Traws Pharma Files for Potential Sale of 128.9 Million Shares | MT |
Jun. 21 | Traws Pharma, Inc. Announces Resignation of Steven M. Fruchtman as President and Chief Scientific Officer, Oncology | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-43.67% | 10.88M | |
+25.83% | 46.56B | |
+45.38% | 41.67B | |
+0.69% | 41.16B | |
+30.52% | 32.4B | |
+22.30% | 28.18B | |
-6.35% | 28.1B | |
+49.25% | 14.52B | |
+49.18% | 13.74B | |
+3.45% | 12.17B |
- Stock Market
- Equities
- TRAW Stock
- News Traws Pharma, Inc.
- Transcript : Onconova Therapeutics, Inc., Q3 2020 Earnings Call, Nov 12, 2020